May 18, 2022 4:30pm EDT 22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform
May 13, 2022 9:16am EDT 22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company
May 05, 2022 6:00am EDT 22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the First Quarter 2022
Apr 29, 2022 9:30am EDT 22nd Century Group (Nasdaq: XXII) Expects VLN® Menthol King Reduced Nicotine Cigarettes To Be Exempted From FDA’s Proposed Ban on Menthol Cigarettes
Apr 27, 2022 9:25am EDT 22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partner’s Virtual Spring Consumer Cannabis Conference
Apr 14, 2022 8:00am EDT 22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022
Apr 13, 2022 8:00am EDT First Cigarette That "Helps You Smoke Less" Launches National Pilot in Chicagoland
Apr 11, 2022 9:25am EDT 22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer
Mar 28, 2022 9:28am EDT FDA Authorized Reduced-Nicotine Cigarette from 22nd Century Group (Nasdaq: XXII) That ‘Helps You Smoke Less’ Obtains Illinois Tobacco Product Listing
